Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Sudarshan Pharma ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 14 August 2025. The agenda includes considering and approving matters inter alia, though the specific items are not fully visible in this intimation. Given the mid-August timing, this is most likely a meeting to approve the unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). The full agenda and any approved items will be disclosed after the meeting concludes. No financial figures, numbers, or detailed agenda items are available in this filing.
This is a routine regulatory intimation ahead of a board meeting. Investors should wait for the outcome of the meeting on 14 August 2025 for any material announcements, which could include quarterly results, dividend declaration, or other corporate actions. The stock may see some activity around the results announcement, but no specific direction can be inferred from the intimation itself.